Alopecia Areata - Q-AA03

We are recruiting patients between 18 and 75 years of age with severe alopecia areata (AA) to participate in an investigational study. The purpose is to evaluate how effective injections of the investigational drug called ADX-914 is on reducing hair loss in patients with severe AA.
The study consists of receiving an injection under the skin of the investigational product ADX-914 once a week for 4 weeks (4 doses) and then every two weeks over a 32-week period (16 doses). After your 36-week treatment period, there will be a 16-week follow-up period to observe the findings. Your participation in the study may last up to 56 weeks, including a Screening Period of up to 30 days, 36weeks of Study Treatment Period, and a Follow-Up Period of 16 weeks. You will have a total of 25 in person visits throughout the study. Participation in this trial will come at no cost to you. .

* Las preguntas con un asterisco rojo son obligatorias

Empezar cuestionario